mc4r obesity weight loss data

Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison |

Stop Losing 3 Patients to Semaglutide

Stop Losing 3 Patients to Semaglutide Retatrutide produced a 21.4% mean weight loss, the highest among GLP-1 analogs for MC4R-deficient obesity, according to the latest pooled data. This result surpasses tirzepatide’s 14.9% and semaglutide’s 9.6% loss, offering a clear hierarchy for clinicians seeking the most